ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,573 | -57.5% | 38 | -66.1% | 0.00% | – |
| Q1 2023 | $6,059 | +360.4% | 112 | +409.1% | 0.00% | – |
| Q4 2022 | $1,316 | +31.6% | 22 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -75.0% | 22 | -67.2% | 0.00% | – |
| Q2 2022 | $4,000 | – | 67 | +2133.3% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 3 | -94.5% | 0.00% | – |
| Q4 2021 | $4,000 | -33.3% | 55 | -32.1% | 0.00% | – |
| Q3 2021 | $6,000 | +20.0% | 81 | +26.6% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 64 | -12.3% | 0.00% | – |
| Q1 2021 | $6,000 | +200.0% | 73 | +204.2% | 0.00% | – |
| Q3 2020 | $2,000 | -83.3% | 24 | -87.6% | 0.00% | – |
| Q1 2020 | $12,000 | +9.1% | 194 | +16.9% | 0.00% | – |
| Q4 2019 | $11,000 | +37.5% | 166 | +39.5% | 0.00% | – |
| Q2 2019 | $8,000 | +300.0% | 119 | +221.6% | 0.00% | – |
| Q1 2019 | $2,000 | -33.3% | 37 | -22.9% | 0.00% | – |
| Q4 2018 | $3,000 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |